Alteconazole

This classification denotes an antifungal agent with the molecular formula C17H12Cl3N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EA590X615B, chemically known as cis-1-(2-(p-chlorophenyl)-3-(2,4-dichlorophenyl)-2,3-epoxypropyl)-1h-1,2,4-triazole but generally known as alteconazole, which bears US NIH Compound Identifier 172289. European Medicines Agency schedules Alteconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05377MIG. The term ALTECONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). ALTECONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alteconazole under HS 29339990 and SITC 51577. As of Q4 2014, ALTECONAZOLE remains the US FDA Preferred Term for this commodity. Alteconazole bears US NLM identifiers UMLS ID C2698072 and NCI Concept Code C78031. SMILES: CLC1C(C2OC2(CN2NCNC2)C2CCC(CL)CC2)CCC(CL)C1.